Breaking News Instant updates and real-time market news.

CORI

Corium

$12.71

4.39 (52.76%)

07:30
10/15/18
10/15
07:30
10/15/18
07:30

Corium downgraded to Hold from Buy at Needham

Needham analyst Serge Belanger downgraded Corium to Hold from Buy after its "surprising" announcement last week to be acquired by Gurnet Point Capital for $13 per share. The analyst notes that while the deal price is a 50% premium to last close, he believes that some investors may still be disappointed as its donepezil patch product candidate and early-stage pipeline programs may "address significant large market opportunities". Belanger believes that the offer agreement should reflect "the long-term difficulty in seeking a commercial partnership for the donepezil patch" and does not anticipate a competitive bid for Corium.

CORI Corium
$12.71

4.39 (52.76%)

10/15/18
HCWC
10/15/18
DOWNGRADE
Target $13
HCWC
Neutral
Corium downgraded to Neutral from Buy at H.C. Wainwright
H.C. Wainwright analyst Oren Livnat downgraded Corium International to Neutral citing the company's agreement to be acquired by private equity firm Gurnet Point Capital for $12.50 per share plus a 50c contingent value right. The analyst sees the deal closing successfully.
05/15/18
HCWC
05/15/18
NO CHANGE
Target $14
HCWC
Buy
Corium recent pullback overdone, says H.C. Wainwright
H.C. Wainwright analyst Oren Livnat views the recent pullback in shares of Corium International (CORI) as overdone and unwarranted. The stock is down 30% since the company's recapitalization at the end of February, which "is a bit of a mystery," Livnat tells investors in a research note. The analyst is not aware of any negative fundamental developments for the key pipeline driver, a weekly donepezil patch for Alzheimer's, or any material updates to its partner Agile's (AGRX) Twirla contraceptive patch. He reiterates a Buy rating on Corium with a $14 price target.
12/27/17
HCWC
12/27/17
NO CHANGE
Target $14
HCWC
Buy
Corium partner's CRL not 'thesis buster,' says H.C. Wainwright
H.C. Wainwright analyst Oren Livnat says while the complete response letter received by partner Agile Therapeutics (AGRX) is a negative surprise and a delay to Corium's (CORI) nearest-term revenue driver, it is "not a thesis buster." The issues raised in the CRL are not deal breakers for Twirla, and will likely just delay approval by one year, Livnat tells investors in a research note. He lowered his price target for Corium shares to $14 from $15 but reiterates a Buy rating on the name.
12/26/17
JEFF
12/26/17
NO CHANGE
Target $13
JEFF
Buy
Corium's partner's CRL looks addressable, says Jefferies
Jefferies analyst David Steinberg believes the complete repose letter received by Corium's (CORI) partner Agile Therapeutics (AGRX) appears addressable. Management indicated the issues relate to Agile's use of standard square-patch tests to assess its circular patch, Steinberg tells investors in a research note. They believe the adhesion profile is "excellent" and, importantly, data addressing the issue has not yet been reviewed by the FDA, the analyst adds. He notes that Twirla's profitability impact to Corium is relatively low, causing only a modest reduction in out-year estimates from the delayed approval. Steinberg keeps a Buy rating on Corium with a $13 price target.

TODAY'S FREE FLY STORIES

ASMB

Assembly Biosciences

$9.30

0.3 (3.33%)

05:06
10/16/19
10/16
05:06
10/16/19
05:06
Initiation
Assembly Biosciences initiated  »

Mizuho starts Assembly…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

  • 30

    Oct

AVAV

AeroVironment

$57.14

0.02 (0.04%)

05:00
10/16/19
10/16
05:00
10/16/19
05:00
Upgrade
AeroVironment rating change  »

AeroVironment upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PSTG

Pure Storage

$17.65

0.2 (1.15%)

04:57
10/16/19
10/16
04:57
10/16/19
04:57
Upgrade
Pure Storage rating change  »

Pure Storage upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 17

    Dec

BOALY

Boral

$0.00

(0.00%)

04:56
10/16/19
10/16
04:56
10/16/19
04:56
Downgrade
Boral rating change  »

Boral downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

04:55
10/16/19
10/16
04:55
10/16/19
04:55
Conference/Events
Wedbush technology analyst to hold an analyst/industry webcast »

Technology Analyst…

04:55
10/16/19
10/16
04:55
10/16/19
04:55
Conference/Events
Wedbush technology analyst to hold an analyst/industry webcast »

Technology Analyst…

JCOM

j2 Global

$96.34

0.47 (0.49%)

04:55
10/16/19
10/16
04:55
10/16/19
04:55
Conference/Events
j2 Global management to meet with William Blair »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 17

    Oct

  • 01

    Nov

  • 19

    Nov

AUY

Yamana Gold

$3.19

-0.1 (-3.04%)

04:55
10/16/19
10/16
04:55
10/16/19
04:55
Conference/Events
Yamana Gold management to meet with TD Securities »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 25

    Oct

SCS

Steelcase

$18.15

0.29 (1.62%)

04:55
10/16/19
10/16
04:55
10/16/19
04:55
Conference/Events
Steelcase management to meet with Seaport Global »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

TRVI

Trevi Therapeutics

$4.00

-0.55 (-12.09%)

04:55
10/16/19
10/16
04:55
10/16/19
04:55
Conference/Events
Trevi Therapeutics management to meet with Needham »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

CHWY

Chewy

$26.80

1.03 (4.00%)

04:55
10/16/19
10/16
04:55
10/16/19
04:55
Conference/Events
Chewy management to meet with JPMorgan »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

MREO

Mereo BioPharma

$3.58

0.08 (2.29%)

04:55
10/16/19
10/16
04:55
10/16/19
04:55
Conference/Events
Mereo BioPharma management to meet with SVB Leerink »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

04:55
10/16/19
10/16
04:55
10/16/19
04:55
Conference/Events
BTIG to hold a forum »

Energy & Shipping…

04:55
10/16/19
10/16
04:55
10/16/19
04:55
Conference/Events
FBN Securities cannabis analysts to hold a breakfast meeting »

Analysts host Chairman…

04:55
10/16/19
10/16
04:55
10/16/19
04:55
General news
Breaking General news story  »

Chicago Federal Reserve…

04:55
10/16/19
10/16
04:55
10/16/19
04:55
General news
Breaking General news story  »

Week of 10/11 MBA…

04:55
10/16/19
10/16
04:55
10/16/19
04:55
Conference/Events
Wedbush enterprise software analysts to hold an advisor luncheon »

Enterprise Software…

04:55
10/16/19
10/16
04:55
10/16/19
04:55
Conference/Events
FBN Securities media analyst to hold an analyst/industry conference call »

Media & Entertainment…

NXTC

NextCure

$26.93

-0.175 (-0.65%)

04:55
10/16/19
10/16
04:55
10/16/19
04:55
Conference/Events
NextCure management to meet with Piper Jaffray »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

PIRS

Pieris Pharmaceuticals

$3.22

0.01 (0.31%)

04:55
10/16/19
10/16
04:55
10/16/19
04:55
Conference/Events
Pieris Pharmaceuticals management to meet with William Blair »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 17

    Oct

  • 17

    Oct

  • 31

    Oct

CKPT

Checkpoint Therapeutics

$2.10

0.08 (3.96%)

04:55
10/16/19
10/16
04:55
10/16/19
04:55
Conference/Events
Checkpoint Therapeutics management to meet with Lake Street »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 17

    Oct

TTGT

TechTarget

$22.87

0.47 (2.10%)

, SKHCY

Sonic Healthcare

$0.00

(0.00%)

04:55
10/16/19
10/16
04:55
10/16/19
04:55
Conference/Events
Commvault to hold a conference »

Commvault GO 2019 will be…

TTGT

TechTarget

$22.87

0.47 (2.10%)

SKHCY

Sonic Healthcare

$0.00

(0.00%)

NTAP

NetApp

$53.09

0.88 (1.69%)

HPE

HP Enterprise

$15.15

0.21 (1.41%)

HLF

Herbalife Nutrition

$38.08

-0.67 (-1.73%)

FORR

Forrester

$33.93

1.325 (4.06%)

CSCO

Cisco

$46.37

0.33 (0.72%)

CVLT

Commvault

$45.22

-0.24 (-0.53%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 24

    Oct

  • 29

    Oct

  • 29

    Oct

  • 01

    Nov

  • 06

    Nov

  • 12

    Nov

  • 13

    Nov

  • 12

    Dec

FLGT

Fulgent Genetics

$11.14

0.09 (0.81%)

04:55
10/16/19
10/16
04:55
10/16/19
04:55
Conference/Events
Fulgent Genetics management to meet with Piper Jaffray »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 17

    Oct

  • 04

    Nov

ISEE

IVERIC bio

$0.99

-0.0016 (-0.16%)

04:55
10/16/19
10/16
04:55
10/16/19
04:55
Conference/Events
IVERIC bio management to meet with Wedbush »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

TORC

resTORbio

$6.89

-0.09 (-1.29%)

04:55
10/16/19
10/16
04:55
10/16/19
04:55
Conference/Events
resTORbio management to meet with Wedbush »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.